1. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
- Author
-
Carbonell R, Urgelés S, Salgado M, Rodríguez A, Reyes LF, Fuentes YV, Serrano CC, Caceres EL, Bodí M, Martín-Loeches I, Solé-Violán J, Díaz E, Gómez J, Trefler S, Vallverdú M, Murcia J, Albaya A, Loza A, Socias L, Ballesteros JC, Papiol E, Viña L, Sancho S, Nieto M, Del M, Lorente C, Badallo O, Fraile V, Arméstar F, Estella A, Abanses P, Sancho I, Guasch N, and Moreno G
- Subjects
- Biomarkers, C-Reactive Protein analysis, Humans, Predictive Value of Tests, ROC Curve, Retrospective Studies, Bacterial Infections diagnosis, COVID-19 diagnosis, Coinfection diagnosis, Procalcitonin, Respiratory Tract Infections
- Abstract
Background: Procalcitonin (PCT) and C-Reactive Protein (CRP) are useful biomarkers to differentiate bacterial from viral or fungal infections, although the association between them and co-infection or mortality in COVID-19 remains unclear., Methods: The study represents a retrospective cohort study of patients admitted for COVID-19 pneumonia to 84 ICUs from ten countries between (March 2020-January 2021). Primary outcome was to determine whether PCT or CRP at admission could predict community-acquired bacterial respiratory co-infection (BC) and its added clinical value by determining the best discriminating cut-off values. Secondary outcome was to investigate its association with mortality. To evaluate the main outcome, a binary logistic regression was performed. The area under the curve evaluated diagnostic performance for BC prediction., Results: 4635 patients were included, 7.6% fulfilled BC diagnosis. PCT (0.25[IQR 0.1-0.7] versus 0.20[IQR 0.1-0.5]ng/mL, p<0.001) and CRP (14.8[IQR 8.2-23.8] versus 13.3 [7-21.7]mg/dL, p=0.01) were higher in BC group. Neither PCT nor CRP were independently associated with BC and both had a poor ability to predict BC (AUC for PCT 0.56, for CRP 0.54). Baseline values of PCT<0.3ng/mL, could be helpful to rule out BC (negative predictive value 91.1%) and PCT≥0.50ng/mL was associated with ICU mortality (OR 1.5,p<0.001)., Conclusions: These biomarkers at ICU admission led to a poor ability to predict BC among patients with COVID-19 pneumonia. Baseline values of PCT<0.3ng/mL may be useful to rule out BC, providing clinicians a valuable tool to guide antibiotic stewardship and allowing the unjustified overuse of antibiotics observed during the pandemic, additionally PCT≥0.50ng/mL might predict worsening outcomes., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF